X4 Pharmaceuticals, Inc.
CXCR4 inhibitors and uses thereof

Last updated:

Abstract:

The present invention provides compounds, compositions thereof, and methods of using the same.

Status:
Grant
Type:

Utility

Filling date:

27 Jul 2020

Issue date:

19 Apr 2022